April 2011
Volume 52, Issue 14
ARVO Annual Meeting Abstract  |   April 2011
rs5888 Variant Of Scarb1 In Age-related Macular Degeneration
Author Affiliations & Notes
  • James B. Earl
    Ophthalmology, University of California, Irvine, Orange, California
  • Shari R. Atilano
    Ophthalmology, University of California, Irvine, Orange, California
  • Nitin S. Udar
    Ophthalmology, University of California, Irvine, Orange, California
  • Anthony B. Nesburn
    Ophthalmology, University of California, Irvine, Orange, California
  • David S. Boyer
    Ophthalmology, Retina Vitreous Assoc Med Group, Los Angeles, California
  • Cristina M. Kenney
    Ophthalmology, University of California, Irvine, Orange, California
  • Footnotes
    Commercial Relationships  James B. Earl, None; Shari R. Atilano, None; Nitin S. Udar, None; Anthony B. Nesburn, None; David S. Boyer, None; Cristina M. Kenney, None
  • Footnotes
    Support  Discovery Eye Foundation; Lincy Foundation; Guenther Foundation; Iris and B. Gerald Cantor Foundation; Ko Family Foundation; Gilbert Foundation; Research to Prevent Blindness
Investigative Ophthalmology & Visual Science April 2011, Vol.52, 5247. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      James B. Earl, Shari R. Atilano, Nitin S. Udar, Anthony B. Nesburn, David S. Boyer, Cristina M. Kenney; rs5888 Variant Of Scarb1 In Age-related Macular Degeneration. Invest. Ophthalmol. Vis. Sci. 2011;52(14):5247.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Purpose: : To examine the association of the rs5888 Variant of SCARB1 (Genbank accession number NM_001082959.1, NM_005505.4; T>C 63587 [350 A>A] exon 8, 12q24.31) with Age-related Macular Degeneration (AMD).

Methods: : Total DNA was isolated from 115 AMD subjects and 133 age-matched control subjects. All subjects underwent a complete dilated ophthalmic examination by Board certified ophthalmologists including fundus photos, fluorescence and/or indocyanine green angiography. The AMD subjects were further classified as nonexudative (29 subjects) or exudative (86 subjects). The SCARB1 gene was amplified by the Polymerase Chain reaction (PCR) and scored for the rs5888 polymorphism using restriction enzyme digestion with Afe I. Some PCR amplified products were sequenced at the UCLA Sequencing and Genotype Core to verify polymorphisms. Statistical analyses were performed using SISA software.

Results: : Of the AMD patients studied in our population 52.1% were heterozygous for the rs5888 single nucleotide polymorphism (SNP) compared to 51.9% in the control population (Odds Ratio [OR] 0.74, 95% Confidence Intervals [CI] 0.45-1.2). The proportion of AMD homozygotes also did not differ significantly from the control population (OR of TT genotype 1.33, 95% CI 0.72-2.45; OR of CC genotype 1.14, 95%CI 0.66-1.96). Subgroup analysis was also performed to determine if the rs5888 variant was more prevalent in non-exudative, exudative, or control subjects and to determine if statistical significance emerged depending on inheritance pattern (dominant versus recessive). In all analyses, no statistically significant difference was observed.

Conclusions: : Despite a previous report that rs5888 is found in a statistically significantly higher proportion of AMD patients compared to controls, we did not find a significant difference between AMD patients and controls in our population.

Keywords: age-related macular degeneration • genetics 

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.